Blog
![](https://provider.covid-frontline.com/wp-content/uploads/2021/04/Covid_Blog-imagery-3-300x113.png)
COVID-19 Monoclonal Antibodies and Effectiveness Against Variants
The Centers for Disease Control and Prevention (CDC) report that the COVID-19 variant first identified in the U.K.—B.1.1.7—is the most common cause of new infection
April 23, 2021
![](https://provider.covid-frontline.com/wp-content/uploads/2021/04/Covid_Blog-imagery-2-300x113.png)
Messenger RNA Vaccines Against COVID-19 and its Variants
The novel messenger RNA (mRNA) vaccines developed by Pfizer-BioNTech (BNT162b2) and Moderna (mRNA-1273) carry the genetic code the host cell needs to make the surface
April 9, 2021
![](https://provider.covid-frontline.com/wp-content/uploads/2021/04/Covid_Blog-imagery-1-300x113.png)
Coronavirus Variants and their Impact on Treatment
New coronavirus variants are circulating in the United States. The Department of Health and Human Services (HHS) established a SARS-CoV-2 interagency group (SIG) to improve
March 10, 2021